Anamaria Rusu

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
OBJECTIVES Adiponectin is an insulin-sensitizing, anti-inflammatory adipokine with anti-atherogenic actions in the general population. In dialysis patients it is unclear whether adiponectin conserves its protective value or is, on the contrary, associated to worse prognosis. We assessed the predictive value of adiponectin for atherosclerosis related(More)
Carcinoma of the anal canal accounts for 2% of digestive-system cancers, with squamous cell carcinoma the most common histological type. Five-year survival rates range from 78% in patients with local stage disease to only 18% in patients with distant metastases (1). Combined modality therapy consisting of concurrent 5-FluroUracil (5FU), Mitomycin C (MMC)(More)
  • 1